RET and hyperparathyroidism: MTC is usually the presenting tumour in MEN2A, but in 30% of cases, phaeochromocytoma develops first, whereas hyperparathyroidism is an uncommon presentation (Rodriguez et al. 2008, Larsen et al. 2020).